Literature DB >> 20211927

Risk of venous thromboembolism with inflammatory bowel disease.

Tarek Saleh1, Fadi Matta, Abdo Y Yaekoub, Septimiu Danescu, Paul D Stein.   

Abstract

The purpose of this study is to determine the incidence of venous thromboembolism (VTE) in patients with ulcerative colitis and patients with Crohn disease. The number of patients discharged from hospitals throughout the United States with a diagnostic code for ulcerative colitis and for Crohn disease from 1979 through 2005 was obtained from the National Hospital Discharge Survey. The incidence of VTE among medical patients with ulcerative colitis was 21 000 of 1 129 000 (1.85%) and among medical patients who had no inflammatory bowel disease, the incidence was 10 421 000 of 918 570 000 (1.13%; relative risk 1.64, 95% confidence interval [CI] = 1.62-1.66). The incidence of VTE among medical patients with Crohn disease was less than those with ulcerative colitis, 22 000 of 1 803 000 (1.22%). The risk, compared with patients who did not have inflammatory bowel disease, was only marginally increased (relative risk 1.08, 95% CI = 1.06-1.09).

Entities:  

Mesh:

Year:  2010        PMID: 20211927     DOI: 10.1177/1076029609360528

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  14 in total

1.  Psoriasis is associated with a greater risk of incident venous thromboembolism: the Iowa Women's Health Study.

Authors:  P L Lutsey; A E Prizment; A R Folsom
Journal:  J Thromb Haemost       Date:  2012-04       Impact factor: 5.824

Review 2.  Cardiovascular complications in inflammatory bowel disease.

Authors:  Rudolf Schicho; Gunther Marsche; Martin Storr
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

Review 3.  Thromboembolic complications in inflammatory bowel disease.

Authors:  Darina Kohoutova; Paula Moravkova; Peter Kruzliak; Jan Bures
Journal:  J Thromb Thrombolysis       Date:  2015-05       Impact factor: 2.300

Review 4.  Inflammatory bowel disease and thromboembolism.

Authors:  Petros Zezos; Georgios Kouklakis; Fred Saibil
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

5.  Inflammatory bowel disease and thromboembolic events: a c'lot to learn.

Authors:  Ana Catarina Carvalho; Juliana Pinho; Eugénia Cancela; Hugo Marcelo Vieira; Américo Silva; Paula Ministro
Journal:  Therap Adv Gastroenterol       Date:  2022-05-25       Impact factor: 4.802

6.  Venous thromboembolism in patients with inflammatory bowel diseases: a case-control study of risk factors.

Authors:  Elizabeth A Scoville; Gauree G Konijeti; Deanna D Nguyen; Jenny Sauk; Vijay Yajnik; Ashwin N Ananthakrishnan
Journal:  Inflamm Bowel Dis       Date:  2014-04       Impact factor: 5.325

Review 7.  Venous thrombosis and prothrombotic factors in inflammatory bowel disease.

Authors:  Fernando Magro; João-Bruno Soares; Dália Fernandes
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

8.  Left Ventricular Thrombosis in Ulcerative Colitis.

Authors:  Tarek Saleh
Journal:  Case Rep Gastroenterol       Date:  2010-07-21

9.  Clinical features in patients with pulmonary embolism at a community hospital: analysis of 4 years of data.

Authors:  Navin Bajaj; Andrew L Bozarth; Juan Guillot; Joseph Kojokittah; Sri Ram Appalaneni; Cesar Cestero; Raymond Kofi Amankona; James A Pippim
Journal:  J Thromb Thrombolysis       Date:  2014-04       Impact factor: 2.300

10.  Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort study.

Authors:  Ole Ahlehoff; Gunnar Hilmar Gislason; Jesper Lindhardsen; Mette Gitz Charlot; Casper Haslund Jørgensen; Jonas Bjerring Olesen; Ditte-Marie Bretler; Lone Skov; Christian Torp-Pedersen; Peter Riis Hansen
Journal:  PLoS One       Date:  2011-03-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.